SLS EBITDA | SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc. (SLS) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$10.63M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$9.25M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$7.08M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$6.87M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2011-12-31 to 2017-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$10.63M	(m)	(m)	(m)	(m)	-$7.59M*	$0.00*	(m)	(m)	(m)
2026-03-31	Reported	(m)	-$9.25M	(m)	(m)	(m)	(m)	-$8.85M	$0.00	(m)	(m)	(m)
2025-09-30	Reported	(m)	-$7.08M	(m)	(m)	(m)	(m)	-$7.07M*	$0.00	(m)	$2.87M	(m)
2025-06-30	Reported	(m)	-$6.87M	(m)	(m)	(m)	(m)	-$7.33M*	$0.00	(m)	$3.00M	(m)
2025-03-31	Reported	(m)	-$6.06M	(m)	(m)	(m)	(m)	-$9.07M	$0.00	(m)	$2.86M	(m)
2024-09-30	Reported	(m)	-$7.33M	(m)	(m)	(m)	(m)	-$7.81M*	$0.00	(m)	$2.97M	(m)
2024-06-30	Reported	(m)	-$7.62M	(m)	(m)	(m)	(m)	-$9.68M*	$0.00	(m)	$2.44M	(m)
2024-03-31	Reported	(m)	-$9.64M	(m)	(m)	(m)	(m)	-$10.76M	$0.00	(m)	$4.53M	(m)
2023-09-30	Reported	(m)	-$9.36M	(m)	$0.00	(m)	(m)	-$6.89M*	$0.00	(m)	$3.55M	(m)
2023-06-30	Reported	(m)	-$9.05M	(m)	$0.00	(m)	(m)	-$7.57M*	$0.00	(m)	$3.13M	(m)
2023-03-31	Reported	(m)	-$11.28M	(m)	$0.00	(m)	(m)	-$12.13M	$0.00	(m)	$4.11M	(m)
2022-09-30	Reported	(m)	-$7.15M	(m)	$0.00	(m)	(m)	-$5.75M*	$0.00	(m)	$2.86M	(m)
2022-06-30	Reported	(m)	-$8.62M	(m)	$0.00	(m)	(m)	-$5.76M*	$0.00	(m)	$3.09M	(m)
2022-03-31	Reported	(m)	-$16.73M	(m)	$1.00M	(m)	(m)	-$7.15M	$100.00K	(m)	$3.02M	(m)
2021-09-30	Reported	(m)	-$6.98M	(m)	$0.00	(m)	(m)	-$5.88M*	$0.00	$4.54M	$2.44M	(m)
2021-06-30	Reported	(m)	-$4.45M	(m)	$1.90M	(m)	(m)	-$4.90M*	$100.00K	$3.46M	$2.80M	(m)
2021-03-31	Reported	(m)	-$2.25M	(m)	$5.70M	(m)	(m)	-$10.27M	$100.00K	$4.28M	$3.56M	(m)
2020-09-30	Reported	(m)	-$4.49M	(m)	$0.00	(m)	(m)	-$3.63M*	$0.00	$2.37M	$2.13M	(m)
2020-06-30	Reported	(m)	-$4.27M	(m)	$0.00	(m)	(m)	-$3.38M*	$0.00	$2.28M	$1.99M	(m)
2020-03-31	Reported	(m)	-$4.06M	(m)	$0.00	(m)	(m)	-$6.83M	$0.00	$1.86M	$2.20M	(m)
2017-09-30	Reported	-$4.44M*	-$4.46M	$25.00K*	(m)	(m)	(m)	-$2.40M*	(m)	$1.07M	$3.22M	$63.00K
2017-06-30	Reported	-$4.89M*	-$4.91M	$25.00K*	(m)	(m)	(m)	-$3.05M*	(m)	$1.83M	$3.84M	$117.00K
2017-03-31	Reported	-$5.06M	(m)	(m)	(m)	(m)	(m)	-$3.80M	(m)	$2.18M	$2.29M	(m)
2016-12-31	Reported	$8.65M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$6.44M*	-$6.47M	$30.00K*	(m)	(m)	$0.00*	-$12.21M*	(m)	$3.62M	$2.85M	(m)
2016-06-30	Reported	-$9.23M*	-$9.29M	$59.00K*	(m)	(m)	$0.00*	-$11.49M*	(m)	$6.17M	$3.12M	(m)
2016-03-31	Reported	-$8.96M	(m)	(m)	(m)	(m)	$6.00K	-$13.22M	(m)	$5.44M	$3.52M	(m)
2015-12-31	Reported	-$7.79M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$8.51M*	-$8.63M	$123.00K*	(m)	(m)	$47.00K*	-$9.46M*	(m)	$5.74M	$2.90M	(m)
2015-06-30	Reported	-$9.00M*	-$9.08M	$83.00K*	(m)	(m)	$16.00K*	-$11.86M*	(m)	$7.20M	$1.89M	(m)
2015-03-31	Reported	-$8.81M	(m)	(m)	(m)	-320.51%	$18.00K	-$11.56M	(m)	$5.83M	$3.09M	(m)
2014-12-31	Reported	-$9.95M	(m)	(m)	(m)	-311.33%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$10.69M*	-$10.57M	-$121.00K*	(m)	(m)	$19.00K*	-$11.12M*	(m)	$7.03M	$3.54M	$0.00
2014-06-30	Reported	-$15.55M*	-$15.78M	$229.00K*	(m)	(m)	$7.00K*	-$12.97M*	(m)	$8.07M	$9.60M	$0.00
2014-03-31	Reported	-$11.62M	(m)	(m)	(m)	-534.61%	$22.00K	-$8.05M	(m)	$6.77M	$6.83M	$0.00
2013-12-31	Reported	-$6.88M	(m)	(m)	(m)	-522.48%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$6.77M*	-$6.89M	$127.00K*	(m)	(m)	$104.00K*	-$7.98M*	(m)	$3.63M	$4.13M	$1.16M
2013-06-30	Reported	-$7.95M*	-$7.99M	$39.00K*	(m)	(m)	(m)	-$7.12M*	(m)	$5.28M	$2.71M	$1.54M
2013-03-31	Reported	-$6.61M	(m)	(m)	(m)	(m)	(m)	-$5.33M	(m)	$5.08M	$1.53M	-$2.76M
2012-12-31	Reported	-$5.58M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$5.53M*	-$5.53M	$3.00K*	(m)	(m)	(m)	-$4.17M*	(m)	$4.17M	(m)	(m)
2012-03-31	Reported	(m)	(m)	$42.00K	(m)	(m)	(m)	-$4.88M	(m)	$2.66M	(m)	(m)
2011-06-30	Reported	-$4.58M*	-$4.62M	$47.00K*	(m)	(m)	$13.00K*	-$4.06M*	(m)	$329.00K	(m)	(m)
2011-03-31	Reported	(m)	(m)	$37.00K	(m)	(m)	$40.00K	-$3.03M	(m)	$2.16M	(m)	(m)
2010-06-30	Reported	(m)	-$4.75M	(m)	(m)	(m)	(m)	(m)	(m)	$2.26M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$28.27M	(m)	(m)	(m)	(m)	-$28.39M	$0.00	(m)	$12.25M	$0.00
2024-12-31	Reported	(m)	-$31.51M	(m)	(m)	(m)	(m)	-$35.40M	$0.00	(m)	$12.42M	$0.00
2023-12-31	Reported	(m)	-$37.87M	(m)	$0.00	(m)	(m)	-$31.41M	$0.00	(m)	$13.86M	$0.00
2022-12-31	Reported	(m)	-$41.95M	(m)	$1.00M	(m)	(m)	-$23.81M	$100.00K	(m)	$12.58M	$0.00
2021-12-31	Reported	(m)	-$25.29M	(m)	$7.60M	(m)	(m)	-$26.02M	$200.00K	$15.67M	$11.32M	-$237.00K
2020-12-31	Reported	(m)	-$16.98M	(m)	$1.90M	(m)	(m)	-$10.42M	$0.00	$9.28M	$9.60M	-$17.00K
2019-12-31	Reported	(m)	-$20.04M	(m)	$0.00	(m)	(m)	-$17.64M	(m)	$7.29M	$9.92M	-$81.00K
2017-12-31	Reported	(m)	-$23.04M	(m)	(m)	(m)	(m)	-$10.99M	(m)	$6.07M	$15.09M	$253.00K
2016-12-31	Reported	-$15.99M	(m)	(m)	(m)	(m)	$6.00K	-$11.85M	(m)	$11.39M	$4.59M	$1.00K
2015-12-31	Reported	-$34.11M	(m)	(m)	(m)	(m)	$153.00K	-$48.16M	(m)	(m)	(m)	$365.00K
2014-12-31	Reported	-$43.81M	(m)	(m)	(m)	-470.16%	$57.00K	-$42.87M	(m)	(m)	(m)	$0.00
2013-12-31	Reported	-$28.2M	(m)	(m)	(m)	-1134.02%	$320.00K	-$28.93M	(m)	(m)	(m)	$1.05M
2012-12-31	Reported	-$21.15M	(m)	(m)	(m)	(m)	(m)	-$20.97M	(m)	$14.61M	(m)	-$1.05M
2011-12-31	Reported	-$12.32M	(m)	(m)	(m)	(m)	$53.00K	-$14.67M	(m)	$3.85M	(m)	(m)
2010-12-31	Reported	(m)	(m)	$172.00K	(m)	(m)	$106.00K	-$10.26M	(m)	$7.87M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
uniQure N.V. (QURE)		$2.416B	-4.93
Vera Therapeutics, Inc. (VERA)	United States	$2.402B	-7.67
Harmony Biosciences Holdings, Inc. (HRMY)	United States	$2.399B	11.67
Nurix Therapeutics, Inc. (NRIX)	United States	$2.457B	-5.39
Mineralys Therapeutics, Inc. (MLYS)	United States	$2.353B	-6.82
Viridian Therapeutics, Inc.\DE (VRDN)	United States	$2.342B	-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)	United States	$2.517B	-24.63
Immunome Inc. (IMNM)	United States	$2.538B	-9.45
Disc Medicine, Inc. (IRON)	United States	$2.553B	-11.40
Zai Lab Ltd (ZLAB)		$2.241B	-113.34